ISIC Q86 · Andorra · 2 publishers
Healthcare in Andorra
347 verified figures for Andorra, covering 13 indicators from 2 primary sources. Every figure links to the report it came from.
Andorra compared
| Measure | Andorra | Highest country |
|---|---|---|
| Current health expenditure (CHE) as percentage of GDP (%) | 7.7%Andorra · 2023 | 27.1%Tuvalu · 2023 |
| Current health expenditure (CHE) per capita (US$) | 3,605.2 USDAndorra · 2023 | 13,473.2 USDUnited States · 2023 |
| Domestic general government health expenditure as percentage of GDP (%) | 5.45%Andorra · 2023 | 19.7%Tuvalu · 2023 |
The short version
Key takeaways
Market size and output 3
- Current health expenditure (CHE) per capita in Andorra (US$) was 3,605.2 USD in 2023 (WHO). WHO ↗ T1 Official
- Current health expenditure (CHE) as percentage of GDP in Andorra (%) was 7.7% in 2023 (WHO). WHO ↗ T1 Official
- Domestic general government health expenditure as percentage of GDP in Andorra (%) was 5.45% in 2023 (WHO). WHO ↗ T1 Official
Adoption and share 3
- DTP3 immunization coverage among 1-year-olds in Andorra (%) was 98% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds in Andorra (%) was 99% in 2025 (WHO). WHO ↗ T1 Official
- Measles-containing-vaccine second-dose (MCV2) immunization coverage in Andorra (%) was 96% in 2025 (WHO). WHO ↗ T1 Official
Other measures 4
- Life expectancy at birth, total in Andorra (years) was 84.2 years in 2024 (World Bank). World Bank ↗ T1 Official
- Adult obesity prevalence in Andorra (age-standardized, %) was 17.1% in 2024 (WHO). WHO ↗ T1 Official
- Adult obesity prevalence: female in Andorra (age-standardized, %) was 15.2% in 2024 (WHO). WHO ↗ T1 Official
- Adult obesity prevalence: male in Andorra (age-standardized, %) was 18.8% in 2024 (WHO). WHO ↗ T1 Official
The complete table
Healthcare data for Andorra
Every row links to its own page with the full source, verbatim quote and citation.
347 data points across 13 indicators. Each line shows the latest value; open a line for earlier periods and forecasts.
IndicatorPeriodValueSourceType
Adult obesity prevalence (age-standardized, %)+34 more202417.1%WHOT12024estimate→
Adult obesity prevalence: female (age-standardized, %)+34 more202415.2%WHOT12024estimate→
Adult obesity prevalence: male (age-standardized, %)+34 more202418.8%WHOT12024estimate→
Current health expenditure (CHE) as percentage of GDP (%)+23 more20237.7%WHOT12023actual→
Current health expenditure (CHE) per capita (US$)+23 more20233,605.2 USDWHOT12023actual→
Domestic general government health expenditure as percentage of GDP (%)+23 more20235.45%WHOT12023actual→
DTP3 immunization coverage among 1-year-olds (%)+25 more202598%WHOT12025estimate→
Life expectancy at birth, total (years)+64 more202484.2 yearsWorld BankT12024estimate→
Measles-containing-vaccine first-dose (MCV1) immunization coverage among 1-year-olds (%)+25 more202599%WHOT12025estimate→
Measles-containing-vaccine second-dose (MCV2) immunization coverage (%)+25 more202596%WHOT12025estimate→
Tobacco use prevalence (ages 15+, age-standardized, %)+8 more202435.5%WHOT12024estimate→
Tobacco use prevalence: female (ages 15+, age-standardized, %)+8 more202436.4%WHOT12024estimate→
Tobacco use prevalence: male (ages 15+, age-standardized, %)+8 more202434.6%WHOT12024estimate→
Primary documents
Sources
| Document | Publisher | Authority tier | Accessed | Locator | Data points |
|---|---|---|---|---|---|
| World Bank life expectancy at birth (total, years) Dataset | World Bank | T1 Official | 3 Oct 2026 | SP.DYN.LE00.IN: {"countryiso3code":"AND","date":"2024","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"AND","date":"2023","indicator.id":"SP.DYN.LE00.IN"}; SP.DYN.LE00.IN: {"countryiso3code":"AND","date":"2022","indicator.id":"SP.DYN.LE00.IN"} | 65 |
| WHO adult obesity prevalence (age-standardized, both sexes) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, female) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO adult obesity prevalence (age-standardized, male) Dataset | WHO | T1 Official | 2 Oct 2026 | NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; NCD_BMI_30A: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 35 |
| WHO current health expenditure (CHE) as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHEGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHEGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO current health expenditure (CHE) per capita in US$ Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_CHE_pc_US_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_CHE_pc_US_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF DTP3 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS4_100: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS4_100: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS4_100: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO domestic general government health expenditure as percentage of GDP Dataset | WHO | T1 Official | 2 Oct 2026 | GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"}; GHED_GGHE-DGDP_SHA2011: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2021"} | 24 |
| WHO/UNICEF MCV1 immunization coverage among 1-year-olds Dataset | WHO | T1 Official | 2 Oct 2026 | WHS8_110: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2025"}; WHS8_110: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; WHS8_110: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO/UNICEF MCV2 immunization coverage by recommended age Dataset | WHO | T1 Official | 2 Oct 2026 | MCV2: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2025"}; MCV2: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; MCV2: {"SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"} | 26 |
| WHO tobacco use prevalence (ages 15+, age-standardized, both sexes) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_BTSX","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
| WHO tobacco use prevalence (ages 15+, age-standardized, female) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_FMLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
| WHO tobacco use prevalence (ages 15+, age-standardized, male) Dataset | WHO | T1 Official | 2 Oct 2026 | M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2024"}; M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2023"}; M_Est_tob_curr_std: {"Dim1":"SEX_MLE","SpatialDim":"AND","SpatialDimType":"COUNTRY","TimeDim":"2022"} | 9 |
Report snapshots are retained internally for verification only and are never redistributed. Where a figure comes from a paywalled report, only the number published in its public summary is recorded.
All 347 collected records for Andorra are published as verified.
Cite & reuse
Cite this page
Data on this page is published under CC BY 4.0. You may reuse it, including commercially, provided you attribute it. Each figure's own page carries APA, MLA, Chicago and BibTeX citations naming its original publisher.
StatOrigin. (2026). Healthcare in Andorra: statistics. Retrieved from https://statorigin.org/industries/healthcare/andorra